Market Overview

Sanofi To Buy Genfar

Share:
Related SNY
JMP Sees A 'Negative Market Tone' In Biotechnology
Genzyme Initiates Phase 1/2 Clinical Trial to Evaluate Olipudase Alfa in Pediatric Patients
No Letting Up In Pharma As First-Half Gains Outweigh Losses (Seeking Alpha)

Sanofi SA (NYSE: SNY) announced its plans to buy Colombian group Genfar SA.

Genfar posted sales of $133 million in 2011. The transaction is likely to complete in the first quarter of 2013. However, financial details of the deal were not disclosed.

Sanofi shares closed at $44.02 yesterday.

Posted-In: merger and acquisitionNews M&A

 

Related Articles (SNY)

Around the Web, We're Loving...

Get Benzinga's Newsletters